Primary Outcome Analysis of Invasive Disease-Free Survival for MonarchE: Abemaciclib Combined With Adjuvant Endocrine Therapy for High-Risk Early Breast Cancer-MedSci.cn

Primary Outcome Analysis of Invasive Disease-Free Survival for MonarchE: Abemaciclib Combined With Adjuvant Endocrine Therapy for High-Risk Early Breast Cancer

O'Shaughnessy, JA; Johnston, S; Harbeck, N; Toi, M; Im, YH; Reinisch, M; Shao, ZM; Lehtinen, PLK; Huang, CS; Tryakin, A; Goetz, M; Rugo, HS; Senkus, E; Testa, L; Andersson, M; Tamura, K; Steger, GG; Del Mastro, L; Cox, J; Forrester, T; Sherwood, S; Li, XL; Wei, R; Martin, M; Rastogi, P

O'Shaughnessy, JA (corresponding author), Texas Oncol, Dallas, TX USA.

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Primary Outcome Analysis of Invasive Disease-Free Survival for MonarchE: Abemaciclib Combined With Adjuvant Endocrine Therapy for High-Risk Early Breast Cancer

科室

工具

服务